BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey. World J Gastroenterol 2009; 15(20): 2433-2440 [PMID: 19468990 DOI: 10.3748/wjg.15.2433]
URL: https://www.wjgnet.com/1007-9327/full/v15/i20/2433.htm
Number Citing Articles
1
A. Cequera, M.C. García de León Méndez. Biomarkers for liver fibrosis: Advances, advantages and disadvantagesRevista de Gastroenterología de México (English Edition) 2014; 79(3): 187 doi: 10.1016/j.rgmxen.2014.07.001
2
Elif Ozdogan, Cigdem Arikan. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapyClinical and Experimental Pediatrics 2023; 66(3): 110 doi: 10.3345/cep.2022.00367
3
Waleed Ghanima, Peter Junker, Hans Carl Hasselbalch, Leonardo Boiocchi, Julia T. Geyer, Xingmin Feng, Sif Gudbrandsdottir, Attilio Orazi, James B. Bussel. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agentsBritish Journal of Haematology 2011; 155(2): 248 doi: 10.1111/j.1365-2141.2011.08845.x
4
Axel M. Gressner, Torsten Arndt. Lexikon der Medizinischen Laboratoriumsdiagnostik2013; : 477 doi: 10.1007/978-3-642-12921-6_6
5
Timo Rath, Lisa Hage, Marion Kügler, Katrin Menendez Menendez, Reinhart Zachoval, Lutz Naehrlich, Richard Schulz, Martin Roderfeld, Elke Roeb, Dominik Hartl. Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver DiseasePLoS ONE 2013; 8(3): e58955 doi: 10.1371/journal.pone.0058955
6
Gavin E. Arteel, David W. Crabb. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 41 doi: 10.1007/978-3-319-20538-0_3
7
Tomislav Horvat, Brigitte Landesmann, Alfonso Lostia, Mathieu Vinken, Sharon Munn, Maurice Whelan. Adverse outcome pathway development from protein alkylation to liver fibrosisArchives of Toxicology 2017; 91(4): 1523 doi: 10.1007/s00204-016-1814-8
8
Sakil Kulkarni, Stephen M. Roper, Janis M. Stoll. Biochemical and Molecular Basis of Pediatric Disease2021; : 229 doi: 10.1016/B978-0-12-817962-8.00030-5
9
Keyur Patel. Noninvasive tools to assess liver diseaseCurrent Opinion in Gastroenterology 2010; 26(3): 227 doi: 10.1097/MOG.0b013e3283383c68
10
Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. Advances in Clinical Chemistry 2013; 61: 67 doi: 10.1016/B978-0-12-407680-8.00004-X
11
A. M. Gressner, O. A. Gressner. Lexikon der Medizinischen Laboratoriumsdiagnostik2017; : 1 doi: 10.1007/978-3-662-49054-9_1162-1
12
Dieter Vanderschaeghe, Ákos Szekrényes, Christian Wenz, Marcus Gassmann, Natasha Naik, Maggie Bynum, Hongfeng Yin, Joris Delanghe, Andras Guttman, Nico Callewaert. High-Throughput Profiling of the Serum N-Glycome on Capillary Electrophoresis Microfluidics Systems: Toward Clinical Implementation of GlycoHepatoTestAnalytical Chemistry 2010; 82(17): 7408 doi: 10.1021/ac101560a
13
Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese. Molecular Serum Markers of Liver FibrosisBiomarker Insights 2012; 7: BMI.S10009 doi: 10.4137/BMI.S10009
14
Toru Mizuguchi, Masaki Kawamoto, Makoto Meguro, Thomas T. Hui, Koichi Hirata. Preoperative liver function assessments to estimate the prognosis and safety of liver resectionsSurgery Today 2014; 44(1): 1 doi: 10.1007/s00595-013-0534-4
15
Timo Rath, Katrin Menendez Menendez, Marion Kügler, Lisa Hage, Christian Wenzel, Richard Schulz, Jürgen Graf, Lutz Nährlich, Elke Roeb, Martin Roderfeld. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver diseaseDigestive and Liver Disease 2012; 44(9): 780 doi: 10.1016/j.dld.2012.04.008
16
Peter Jarčuška, Martin Janičko, Eduard Veselíny, Pavol Jarčuška, Ľubomír Skladaný. Circulating markers of liver fibrosis progressionClinica Chimica Acta 2010; 411(15-16): 1009 doi: 10.1016/j.cca.2010.04.009
17
Toni Segovia-Silvestre, Vedrana Reichenbach, Guillermo Fernández-Varo, Efstathios Vassiliadis, Natasha Barascuk, Manuel Morales-Ruiz, Morten A Karsdal, Wladimiro Jiménez. Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosisFibrogenesis & Tissue Repair 2011; 4(1) doi: 10.1186/1755-1536-4-19
18
A. Cequera, M.C. García de León Méndez. Biomarcadores para fibrosis hepática, avances, ventajas y desventajasRevista de Gastroenterología de México 2014; 79(3): 187 doi: 10.1016/j.rgmx.2014.05.003
19
E. Roeb. Diagnostik der nichtalkoholischen SteatohepatitisDer Gastroenterologe 2010; 5(2): 108 doi: 10.1007/s11377-009-0372-5
20
Roy A. Sherwood, Adrian Bomford. Clinical Biochemistry: Metabolic and Clinical Aspects2014; : 231 doi: 10.1016/B978-0-7020-5140-1.00013-4
21
Waleed Ghanima, Leonardo Boiocchi, Christina S. Lee, Xingmin Feng, Julia Turbiner Geyer, Sif Gudbrandsdottir, Attilio Orazi, Peter Junker, James B. Bussel. Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatmentPlatelets 2019; 30(2): 222 doi: 10.1080/09537104.2017.1411586
22
Mohamed M. Omran, Khaled Farid, Tarek M. Emran, Ahmed A. Attallah. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patientsArab Journal of Gastroenterology 2011; 12(2): 74 doi: 10.1016/j.ajg.2011.04.006
23
Minnie Malik, James Segars, William H. Catherino. Integrin β1 regulates leiomyoma cytoskeletal integrity and growthMatrix Biology 2012; 31(7-8): 389 doi: 10.1016/j.matbio.2012.09.005
24
Tomomi Masuda, Eiji Miyoshi. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topicscclm 2011; 49(6): 959 doi: 10.1515/CCLM.2011.152
25
Valeria R Mas, Robert A Fisher, Kellie J Archer, Daniel G Maluf. Proteomics and liver fibrosis: identifying markers of fibrogenesisExpert Review of Proteomics 2009; 6(4): 421 doi: 10.1586/epr.09.59
26
A. M. Gressner, O. A. Gressner. Lexikon der Medizinischen LaboratoriumsdiagnostikSpringer Reference Medizin 2019; : 899 doi: 10.1007/978-3-662-48986-4_1162
27
Diana Vetter, Scott L. Friedman. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 110 doi: 10.1016/B978-0-323-34062-5.00007-8
28
Abdurrahman Sagir, Birgit Glaubach, Kurtulus Sahin, Dirk Graf, Andreas Erhardt, Mark Oette, Dieter Häussinger. Transient Elastography for the Detection of Liver Damage in Patients with HIVInfectious Diseases and Therapy 2015; 4(3): 355 doi: 10.1007/s40121-015-0073-y
29
Dieter Vanderschaeghe, Andras Guttman, Nico Callewaert. Clinical Applications of Capillary ElectrophoresisMethods in Molecular Biology 2013; 919: 87 doi: 10.1007/978-1-62703-029-8_9
30
MM Sira, HA El-Araby, EM Ghoneim, HA Konsowa, EH El-Mwafy. Serum YKL-40 (Chitinase-3-Like Protein 1) Compared to APRI and FIB-4 in Predicting Liver Fibrosis in Children with Chronic Hepatitis CArchives of Hepatitis Research 2016; 2(1): 015 doi: 10.17352/ahr.000006
31
Matthew L. Cowan, Tony M. Rahman, Sanjeev Krishna. Proteomic approaches in the search for biomarkers of liver fibrosisTrends in Molecular Medicine 2010; 16(4): 171 doi: 10.1016/j.molmed.2010.01.006
32
Timo Rath, Martin Roderfeld, Can Güler, Christian Wenzel, Jürgen Graf, Frigga Beitinger, Elke Roeb, Reinhart Zachoval. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosisScandinavian Journal of Gastroenterology 2011; 46(11): 1369 doi: 10.3109/00365521.2011.613949
33
J.I. Beier, G.E. Arteel. Comprehensive Toxicology2018; : 443 doi: 10.1016/B978-0-12-801238-3.95666-6
34
Olav A. Gressner, Meng Fang, Hui Li, Lun Gen Lu, Axel M. Gressner, Chun Fang Gao. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infectionClinica Chimica Acta 2013; 421: 126 doi: 10.1016/j.cca.2013.02.029
35
Medi Kori, Busra Aydin, Gizem Gulfidan, Hande Beklen, Nurdan Kelesoglu, Ayşegul Caliskan Iscan, Beste Turanli, Can Erzik, Betul Karademir, Kazim Yalcin Arga. The Repertoire of Glycan Alterations and Glycoproteins in Human CancersOMICS: A Journal of Integrative Biology 2021; 25(3): 139 doi: 10.1089/omi.2020.0210
36
Nora El-Bassiouni, Noha Amin, S. H. Rizk, M. K. Abo El Azayem, Mona Madkour, Hasan Garem, Raafat Ibrahim, Ola Abo El Nil. Role of Circulating Hematopoietic Fibrocytes in Chronic Hepatitis C Patients Induced Liver FibrosisOpen Access Macedonian Journal of Medical Sciences 2022; 10(B): 1222 doi: 10.3889/oamjms.2022.8123
37
Jung Yeon Joo, In Hyuk Yoo, Hye Ran Yang. Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic SteatohepatitisPediatric Gastroenterology, Hepatology & Nutrition 2024; 27(4): 236 doi: 10.5223/pghn.2024.27.4.236
38
Daniela Cesselli, Antonio Paolo Beltrami, Alessandra Poz, Stefania Marzinotto, Elisa Comisso, Natascha Bergamin, Evgenia Bourkoula, Anja Pucer, Elisa Puppato, Barbara Toffoletto, Marisa Sorrentino, Umberto Baccarani, Claudio Avellini, Carlo Alberto Beltrami. Role of Tumor Associated Fibroblasts in Human Liver Regeneration, Cirrhosis, and CancerInternational Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/120925
39
Konstantinos Kalogeropoulos, Louise Bundgaard, Ulrich auf dem Keller. Extracellular Matrix OmicsBiology of Extracellular Matrix 2020; 7: 157 doi: 10.1007/978-3-030-58330-9_8
40
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, Lakshmaiah Venkataswamy, Muninarayana Chandrappa. Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease ProgressionFuture Science OA 2018; 4(1) doi: 10.4155/fsoa-2017-0083
41
Ulises Osuna-Martínez, Jorge Alberto Reyes-Esparza, Vera L. Petricevich, Rogelio Hernández-Pando, Lourdes Rodríguez-Fragoso. Protective effect of Thymic Humoral Factor on porcine serum-induced hepatic fibrosis and liver damage in Wistar ratsAnnals of Hepatology 2011; 10(4): 540 doi: 10.1016/S1665-2681(19)31523-6
42
Jin-Wook Kim, Sang Hyub Lee, Sook-Hyang Jeong, Haeryoung Kim, Keun Soo Ahn, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han. Increased Urinary Lipocalin-2 Reflects Matrix Metalloproteinase-9 Activity in Chronic Hepatitis C with Hepatic FibrosisThe Tohoku Journal of Experimental Medicine 2010; 222(4): 319 doi: 10.1620/tjem.222.319
43
R. Mihaylov, B. Pencheva, D. Stoeva, A. Ruseva. Non-invasive Diagnostics of Liver FibrosisActa Medica Bulgarica 2017; 44(1): 50 doi: 10.1515/amb-2017-0009
44
José M. Ladero, María C. Cárdenas, Luis Ortega, Andrea González-Pino, Francisca Cuenca, César Morales, Anna Lee-Brunner. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?Annals of Hepatology 2012; 11(5): 648 doi: 10.1016/S1665-2681(19)31437-1
45
Lakshmi Pasumarthy, James Srour. Nonalcoholic Steatohepatitis: A Review of the Literature and Updates in ManagementSouthern Medical Journal 2010; 103(6): 547 doi: 10.1097/SMJ.0b013e3181de0ce0